ICD-10 CODE DESCRIPTION PARTIAL THROMBOPLASTIN TIME (PTT) DLS TEST CODES AND NAMES 2018 MEDICARE NATIONAL COVERAGE DETERMINATION (NCD) - 190.16 CPT CODE(S): 85730 E09.22 Drug or chemical induced diabetes mellitus with diabetic chronic kidney disease E09.29 Drug or chemical induced diabetes mellitus with other diabetic kidney complication
Elevated partial thromboplastin time; Elevated prothrombin time; Partial thromboplastin time increased; Prothrombin time increased; ICD-10-CM R79.1 is grouped within Diagnostic Related Group(s) (MS-DRG v 38.0): 947 Signs and symptoms with mcc; 948 Signs and symptoms without mcc; Convert R79.1 to ICD-9-CM. Code History
The PTT test is an in vitro laboratory test used to assess the intrinsic coagulation pathway and monitor heparin therapy. HCPCS Codes (Alphanumeric, CPT AMA) Code Description 85730 Thromboplastin time, partial (PTT); plasma or whole blood ICD-10-CM Codes Covered by Medicare Program
Abnormal coagulation profile. R79.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2018/2019 edition of ICD-10-CM R79.1 became effective on October 1, 2018. This is the American ICD-10-CM version of R79.1 - other international versions of ICD-10 R79.1 may differ.
NCD - Partial ThromboplastinTime (PTT) (190.16)
The PTT NCD includes in the covered list of ICD-9-CM diagnostic codes code V72. 81 (Pre-operative cardiovascular examination,) code V72. 83 (Other specified pre-operative examination,) and code V72. 84 (Pre-operative examination, unspecified).
R79. 1 - Abnormal coagulation profile | ICD-10-CM.
Partial thromboplastin time (PTT) is a blood test that looks at how long it takes for blood to clot. It can help tell if you have a bleeding problem or if your blood does not clot properly. A related blood test is prothrombin time (PT).
Partial thromboplastin time (PTT) is a blood test that looks at how long it takes for blood to clot. It can help tell if you have a bleeding problem or if your blood does not clot properly. A related blood test is prothrombin time (PT) .
The Centers for Medicare & Medicaid Services (CMS) today expanded Medicare coverage for home blood testing of prothrombin time (PT) International Normalized Ratio (INR) to include beneficiaries who are using the drug warfarin, an anticoagulant (blood thinner) medication, for chronic atrial fibrillation or venous ...
A prothrombin time (PT) is a test used to help detect and diagnose a bleeding disorder or excessive clotting disorder; the international normalized ratio (INR) is calculated from a PT result and is used to monitor how well the blood-thinning medication (anticoagulant) warfarin (Coumadin®) is working to prevent blood ...
The prothrombin time (PT) test measures how quickly blood clots. The partial thromboplastin time (PTT) is mainly used to monitor a person's response to anticoagulant therapies.
The partial thromboplastin time (PTT; also known as activated partial thromboplastin time (aPTT)) is a screening test that helps evaluate a person's ability to appropriately form blood clots. It measures the number of seconds it takes for a clot to form in a sample of blood after substances (reagents) are added.
The standard preoperative workup includes: Prothrombin time (PT) Partial thromboplastin time (PTT) Platelet count (part of CBC)
Basic plasma coagulation function is readily assessed with a few simple laboratory tests: The Partial Thromboplastin Time (PTT), Prothrombin Time (PT), Thrombin Time (TT), or a quantitative fibrinogen determination. The PTT test is an in vitro laboratory test used to assess the intrinsic coagulation pathway and monitor heparin therapy.
I70.362 Atherosclerosis of unspecified type of bypass graft(s) of the extremities with gangrene, left leg I70.363 Atherosclerosis of unspecified type of bypass graft(s) of the extremities with gangrene, bilateral legs I70.368 Atherosclerosis of unspecified type of bypass graft(s) of the extremities with gangrene, other extremity I70.369 Atherosclerosis of unspecified type of bypass graft(s) of the extremities with gangrene, unspecified extremity I70.461 Atherosclerosis of autologous vein bypass graft(s) of the extremities with gangrene, right leg I70.462 Atherosclerosis of autologous vein bypass graft(s) of the extremities with gangrene, left leg I70.463 Atherosclerosis of autologous vein bypass graft(s) of the extremities with gangrene, bilateral legs I70.468 Atherosclerosis of autologous vein bypass graft(s) of the extremities with gangrene, other extremity I70.469 Atherosclerosis of autologous vein bypass graft(s) of the extremities with gangrene, unspecified extremity I70.561 Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with gangrene, right leg I70.562 Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with gangrene, left leg I70.563 Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with gangrene, bilateral legs I70.568 Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with gangrene, other extremity I70.569 Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with gangrene, unspecified extremity I70.661 Atherosclerosis of nonbiological bypass graft(s) of the extremities with gangrene, right leg I70.662 Atherosclerosis of nonbiological bypass graft(s) of the extremities with gangrene, left leg I70.663 Atherosclerosis of nonbiological bypass graft(s) of the extremities with gangrene, bilateral legs I70.668 Atherosclerosis of nonbiological bypass graft(s) of the extremities with gangrene, other extremity I70.669 Atherosclerosis of nonbiological bypass graft(s) of the extremities with gangrene, unspecified extremity I70.761 Atherosclerosis of other type of bypass graft(s) of the extremities with gangrene, right leg I70.762 Atherosclerosis of other type of bypass graft(s) of the extremities with gangrene, left leg I70.763 Atherosclerosis of other type of bypass graft(s) of the extremities with gangrene, bilateral legs
D69.51 Posttransfusion purpura D69.59 Other secondary thrombocytopenia D69.6 Thrombocytopenia, unspecified D69.8 Other specified hemorrhagic conditions D69.9 Hemorrhagic condition, unspecified D75.1 Secondary polycythemia D78.01 Intraoperative hemorrhage and hematoma of the spleen complicating a procedure on the spleen D78.02 Intraoperative hemorrhage and hematoma of the spleen complicating other procedure D78.21 Postprocedural hemorrhage of the spleen following a procedure on the spleen D78.22 Postprocedural hemorrhage of the spleen following other procedure D78.31 Postprocedural hematoma of the spleen following a procedure on the spleen D78.32 Postprocedural hematoma of the spleen following other procedure D86.0 Sarcoidosis of lung D86.1 Sarcoidosis of lymph nodes D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes D86.3 Sarcoidosis of skin D86.81 Sarcoid meningitis D86.82 Multiple cranial nerve palsies in sarcoidosis D86.83 Sarcoid iridocyclitis D86.84 Sarcoid pyelonephritis D86.85 Sarcoid myocarditis D86.86 Sarcoid arthropathy D86.87 Sarcoid myositis D86.89 Sarcoidosis of other sites D86.9 Sarcoidosis, unspecified D89.0 Polyclonal hypergammaglobulinemia D89.1 Cryoglobulinemia D89.2 Hypergammaglobulinemia, unspecified E07.89 Other specified disorders of thyroid E08.21 Diabetes mellitus due to underlying condition with diabetic nephropathy E08.22 Diabetes mellitus due to underlying condition with diabetic chronic kidney disease E08.29 Diabetes mellitus due to underlying condition with other diabetic kidney complication
1. The PTT is not useful in monitoring the effects of war farin on a patient’s coagulation routinely. However, a PTT may be ordered on a patient being treated with warfarin as heparin therapy is being discontinued. A PTT may also be indicated when the PT is markedly prolonged due to warfarin toxicity.
Intraoperative hemorrhage and hematoma of a digestive system organ or structure complicating other procedure K91.840
I70.768 Atherosclerosis of other type of bypass graft(s) of the extremities with gangrene, other extremity I70.769